Ashraf El‐Meanawy

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria

Cary Stelloh, Kenneth P. Allen, David L. Mattson et al. · Translational research · 2011 · 93 citations

Medicine, Nephrology, Physiology +14

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Rajiv Agarwal, Wanzhu Tu, Alfredo E. Farjat et al. · Annals of Internal Medicine · 2023 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +17

Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis

Shenaz Khan, Bassam G. Abu Jawdeh, Monu Goel et al. · Journal of Clinical Investigation · 2014 · 67 citations · Full text

Medicine, Biochemistry, Nephrology +17

Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension

Markus M. Rinschen, Oleg Palygin, Ashraf El‐Meanawy et al. · Nature Communications · 2022 · 65 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17